Company Search:
Advanced Search
Sponsored Links
Helixmith Co Ltd Company Snapshot
Helixmith Co Ltd operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Helixmith Co Ltd with three other pharmaceutical manufacturers in Asia: Solasia Pharma KK of Japan (2018 sales of 318.00 million Japanese Yen [US$2.92 million] of which 100% was Pharmaceutical busi), Tego Science Inc (7.85 billion Korean Won [US$6.59 million] of which 96% was Cell Therapy Products), and Peptron Inc (3.86 billion Korean Won [US$3.24 million] of which 48% was Finished Goods).

Sales Analysis. Helixmith Co Ltd reported sales of 5.28 billion Korean Won (US$4.43 million) for the year ending December of 2018. This represents an increase of 67.2% versus 2017, when the company's sales were 3.16 billion Korean Won. Despite this increase, sales are still well below the level achieved in 2016, when Helixmith Co Ltd reported sales of 6.84 billion Korean Won. The sales level in 2018 was fairly close to the level five years ago: in 2013, Helixmith Co Ltd had sales of 5.75 billion Korean Won.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Helixmith Co Ltd
  Stock Performance Chart for Helixmith Co Ltd
  Stock Data: Recent Stock Performance:
  Current Price (12/6/2019): 80,600
(Figures in Korean Won)
1 Week -11.3%   13 Weeks -16.2%  
4 Weeks -56.1%   52 Weeks -48.2%  
Helixmith Co Ltd Key Data:
  Ticker: 084990 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2018 Sales 5,280,860,221
(Year Ending Jan 2019).
Employees: 57
  Currency: Korean Won Market Cap: 1,724,793,010,200
  Fiscal Yr Ends: December Shares Outstanding: 21,399,417
  Share Type: Common Closely Held Shares: 2,792,386
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.